NCT00657488 2019-10-18Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple MyelomaCelgenePhase 2/3 Completed400 enrolled
NCT00038090 2018-10-31Thalidomide-Dexamethasone for Multiple MyelomaM.D. Anderson Cancer CenterPhase 2/3 Completed83 enrolled
NCT00205751 2013-11-25Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance TherapyAustrian Forum Against CancerPhase 2/3 Completed350 enrolled